# OnCo record nct04293562 (trial). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/trials/nct04293562/>
  a schema:MedicalTrial ;
  onco:kind "trial" ;
  schema:identifier "nct04293562", "NCT04293562" ;
  schema:name "A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations"@en ;
  schema:description "A phase 3 trial of Crisantaspase, Asparaginase, Cytarabine, Daunorubicin, Dexrazoxane, Etoposide, Fludeoxyglucose F-18, Gemtuzumab ozogamicin, Gilteritinib, CPX-351, Methotrexate and Mitoxantrone in Acute myeloid leukaemia, run by Children's Oncology Group, now recruiting."@en ;
  schema:url <https://onco.cc/trials/nct04293562/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://clinicaltrials.gov/study/NCT04293562> ;
  onco:status "recruiting" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:phase "3" ;
  onco:cancers <https://onco.cc/cancers/aml/> ;
  onco:drugs <https://onco.cc/drugs/crisantaspase/>, <https://onco.cc/drugs/asparaginase/>, <https://onco.cc/drugs/cytarabine/>, <https://onco.cc/drugs/daunorubicin/>, <https://onco.cc/drugs/dexrazoxane/>, <https://onco.cc/drugs/etoposide/>, <https://onco.cc/drugs/fludeoxyglucose-f18/>, <https://onco.cc/drugs/gemtuzumab-ozogamicin/>, <https://onco.cc/drugs/gilteritinib/>, <https://onco.cc/drugs/cpx-351/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/drugs/mitoxantrone/> .